Cargando…
Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease
BACKGROUND: In certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative radiation (SABR) compared to patients receiving...
Autores principales: | Mehrens, Dirk, Unterrainer, Marcus, Corradini, Stefanie, Niyazi, Maximilian, Manapov, Farkhad, Westphalen, C. Benedikt, Froelich, Matthias F., Wildgruber, Moritz, Seidensticker, Max, Ricke, Jens, Rübenthaler, Johannes, Kunz, Wolfgang G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239286/ https://www.ncbi.nlm.nih.gov/pubmed/34211842 http://dx.doi.org/10.3389/fonc.2021.667993 |
Ejemplares similares
-
Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer
por: Froelich, Matthias F., et al.
Publicado: (2021) -
Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients
por: Walter, Franziska, et al.
Publicado: (2021) -
In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary
por: Holzgreve, Adrien, et al.
Publicado: (2023) -
Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors
por: Niemoeller, Olivier M, et al.
Publicado: (2013) -
MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients
por: Eze, Chukwuka, et al.
Publicado: (2022)